Sichenzia Ross Friedman Ference LLP Represents Israeli-Based Wellsense on $2.0M Private Placement

Press Release — New York, NY – July 1, 2015 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP (“SRFF”) announced today that the Firm has represented Enhanced Surface Dynamics Inc. D.B.A Wellsense USA, the creator of the Israeli-devised, bedsore monitoring device, on a $2 million private placement of the Company’s preferred stock and warrants.

Wellsense was developed at the Profiscope Campus, an Israeli technology incubator founded by Ran Poliakine, the founder of Powermat Technologies. Wellsense’s patented M.A.P. system uses continuous bedside pressure technology to allow caregivers the ability to monitor patients using pressure distribution data in real time. The Sichenzia Ross Friedman Ference LLP team was led by Partner Gregory Sichenzia, Of Counsel Peter DiCharia and Gary Emmanuel. National Securities Corporation acted as placement agent for the offering.

• Author
• Recent Posts

Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals. We also represent clients in a range of residential and commercial real estate and trusts and estates matters.

Visit SRF's LinkedIn page

Latest posts by Sichenzia Ross Ference LLP (see all)

• Sichenzia Ross Ference LLP Represents Relmada Therapeutics, Inc. in a $115 Million Underwritten Public Offering of Common Stock - December 6, 2019
• Sichenzia Ross Ference Trust & Estate Attorneys Quoted in LegalZoom Article - December 6, 2019
• Sichenzia Ross Ference Represents H-Cyte, Inc. in $6.0 Million Private Placement - December 2, 2019